Acctena | Repositioning Clinical Stage Drugs
Acctena is a Swedish company that aims to reposition “abandoned” drugs to become beneficial medicines for new diseases.
Their strategy is to bring selected drugs directly into phase 2 studies for new clinical use and expanded intellectual property.
